v3.26.1
Stockholder Equity (Tables)
12 Months Ended
Dec. 31, 2025
Stockholder Equity  
Schedule of stock based compensation related to stock option and RSU expected to vest present in operations

 

 

Year Ended

 

 

 

December 31,

2025

 

 

December 31,

2024

 

Research and development

 

$239,267

 

 

$169,078

 

Compensation and related expenses

 

 

2,869,219

 

 

 

1,046,546

 

General and administrative expenses

 

 

438,160

 

 

 

-

 

Total expense

 

$3,546,646

 

 

$1,215,624

 

Schedule of stock option activity

 

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

 

 

 

 

Average

 

 

Aggregate

 

 

Remaining

 

 

 

 

 

Exercise

 

 

Intrinsic

 

 

Contractual

 

 

 

Shares

 

 

Price

 

 

Value

 

 

Life (Years)

 

Options outstanding at December 31, 2024

 

 

1,584,312(i)

 

$9.44

 

 

$3,324,000

 

 

 

5.95

 

Granted

 

 

979,881

 

 

 

4.38

 

 

 

 

 

 

 

 

 

Exercised

 

 

(290,000)

 

 

1.20

 

 

 

1,104,400

 

 

 

 

 

Forfeited

 

 

(565,556)

 

 

12.64

 

 

 

 

 

 

 

 

 

Options outstanding at December 31, 2025

 

 

1,708,637(i)

 

$6.88

 

 

$272,680

 

 

 

7.28

 

Options exercisable at December 31, 2025

 

 

771,492(i)

 

$8.25

 

 

$272,000

 

 

 

4.64

 

Schedule of stock option assumptions

 

 

December 31,

 

 

December 31,

 

 

 

2025

 

 

2024

 

Expected volatility

 

67.81 - 94.60%

 

 

26.20 - 27.39%

 

Expected term (years)

 

5.18 - 6.25

 

 

6.25 Years

 

Risk-free rate

 

3.71 - 4.51%

 

 

3.77 - 4.65%

 

Dividend rate

 

0%

 

0%

Schedule of outstanding nonvested restricted stock

 

 

 

 

 

Weighted-Average

 

 

 

 

 

 

Grant Date

 

 

 

Amount

 

 

Fair Value

 

Nonvested, beginning of the year

 

 

354,929

 

 

$12.30

 

Granted

 

 

1,193,076

 

 

 

4.15

 

Vested

 

 

(198,154)

 

 

6.37

 

Forfeited

 

 

(484,555)

 

 

7.52

 

Nonvested, end of the year

 

 

865,296

 

 

$5.09

 

Schedule of warrant activity

 

 

 

 

 

 

 

 

Weighted

 

 

 

 

 

Weighted

 

 

 

 

Average

 

 

 

 

 

Average

 

 

Aggregate

 

 

Remaining

 

 

 

 

 

Exercise

 

 

Intrinsic

 

 

Contractual

 

 

 

Shares

 

 

Price

 

 

Value

 

 

Life (Years)

 

Warrants outstanding at December 31, 2024

 

 

1,467,524

 

 

$11.25

 

 

$-

 

 

 

4.88

 

Granted

 

 

10,000

 

 

 

12.50

 

 

 

-

 

 

 

-

 

Repurchased

 

 

(600,000)

 

 

11.25

 

 

 

-

 

 

 

-

 

Warrants outstanding at December 31, 2025

 

 

877,524

 

 

$2.06*

 

$90,917

 

 

 

3.88

 

Warrants exercisable at December 31, 2025

 

 

877,524

 

 

$2.06*

 

$90,917

 

 

 

3.88